Lastly, during SARS-CoV-2 infection, prostaglandin E2 (PGE2) was shown to be released via Panx1 channels, contributing to the cytokine storm and pulmonary inflammation observed in COVID-19 patients (26). This evidence concerns the gene PANX1 and COVID-19.